Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Neuroimmune Pharmacol ; 7(4): 835-42, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22926418

RESUMO

We have previously reported that functionally active µ-opioid receptors (MOR) are constitutively expressed at relatively low levels by developing T cells in the thymus. However, very little is known about the regulation of MOR expression by immature T cells. In this report, we first attempted to determine the effect of T cell receptor-induced T cell activation on the expression of MOR. We activated T cells with either the combination of anti-CD3 and CD28, or with superantigen, and observed a substantial increase in MOR transcript expression. We also chose to examine the effect of cytokine-mediated T cell activation on the expression of this opioid receptor. We selected certain cytokines that play a role in T cell development and are known to be present at functional levels in the thymus gland. Our results show that interferon γ (IFNγ), IL-1ß, and IL-2, and in particular transforming growth factor-ß (TGFß), all induced significant increases in MOR transcript expression. On the other hand, both TNFα and IL-7 exhibited much weaker effects on MOR expression. These results show that MOR expression by developing T cells is strongly regulated by several cytokines involved in T cell development in the thymus gland.


Assuntos
Ativação Linfocitária/fisiologia , Receptores Opioides mu/biossíntese , Receptores Opioides mu/efeitos dos fármacos , Linfócitos T/fisiologia , Animais , Southern Blotting , Diferenciação Celular/fisiologia , AMP Cíclico/metabolismo , Interferon gama/farmacologia , Interleucina-1beta/farmacologia , Interleucina-2/farmacologia , Interleucina-7/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , RNA/biossíntese , RNA/isolamento & purificação , Linfócitos T/efeitos dos fármacos , Timo/citologia , Fator de Crescimento Transformador beta/farmacologia , Fator de Necrose Tumoral alfa/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA